![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Abbott Healthcare Products B.v. Weesp Nl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Dydrogesterone, Micronised, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-114 - Rev 01
This Chemical Type CEP, issued on April 26, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2357 associated with this CEP further emphasizes